Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ranchoux (Quebec, Canada), V. Nadeau (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), J. Omura (Quebec, Canada), M. André (Quebec, Canada), J. Dupuis (Montreal, Canada), P. Pibarot (Quebec, Canada), R. Paulin (Quebec, Canada), O. Boucherat (Quebec, Canada), S. Provencher (Quebec, Canada), S. Archer (Quebec, Canada), S. Bonnet (Quebec, Canada), F. Potus (Kingston, Canada). Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease.. 3949

Member's Comments

No comment yet.

Related content which might interest you: Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013 Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Late Breaking Abstract - Diaphragm muscle density and function in chronic obstructive pulmonary disease Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - Right heart structural changes, exercise capacity and stress induced right ventricle dysfunction in non- severe COPD patients without pulmonary hypertension at rest. Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Left ventricular-arterial coupling and cardiac remodeling in patients with idiopathic arterial pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Altered control of cerebral circulation in chronic obstructive pulmonary disease: an early sign of cardiovascular autonomic dysfunction Source: Annual Congress 2008 - COPD Year: 2008 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018 Year: 2019 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018 Year: 2019 Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Chronic obstructive pulmonary disease and cardiac remodeling: gender aspect. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012 Pulmonary arterial hypertension associated with congenital heart disease Source: Eur Respir Rev 2012 21: 328-337 Year: 2012 Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues Source: Eur Respir J 2014; 44: 1121-1122 Year: 2014 Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD) Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation? Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018